StockData
Faeth Therapeutics, Inc. logo

Faeth Therapeutics, Inc. (FTH) income statement

FTHNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 7/30
$8.72−0.32 (-3.54%)

Close on Nov 18, 2026Market cap $225.33MP/E –Yield –

See a number that looks wrong?